Last reviewed · How we verify
NCT02834338: EPMIII
Enhanced Perioperative Mobilization (EPM) Trial
NA trial testing activity tracking for autofeedback in Pancreatic Resection in 110 participants. Completed in 20 July 2017.
20 July 2017
Quick facts
| Lead sponsor | Technische Universität Dresden |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 26 July 2016 |
| Primary completion | 20 July 2017 |
| Estimated completion | 20 July 2017 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- activity tracking for autofeedback
Conditions studied
- Pancreatic Resection — all drugs for Pancreatic Resection →
- Liver Resection — all drugs for Liver Resection →
- Gastric Resection — all drugs for Gastric Resection →
- Colorectal Resection — all drugs for Colorectal Resection →
Sponsor
Technische Universität Dresden — full company profile →
Who can join
Adults 18 to 75, any sex, with Pancreatic Resection or Liver Resection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized Controlled Trial to monitor and increase the postoperative mobilization of the patients undergoing major visceral surgery by giving a continuous autofeedback of the step count using activity tracking wristbands.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Use of Activity Tracking in Major Visceral Surgery-the Enhanced Perioperative Mobilization Trial: a Randomized Controlled Trial.
Wolk S, Linke S, Bogner A, Sturm D, et al · · 2019 · cited 50× · PMID 30298422 · DOI 10.1007/s11605-018-3998-0 -
Use of activity tracking in major visceral surgery-the Enhanced Perioperative Mobilization (EPM) trial: study protocol for a randomized controlled trial.
Wolk S, Meißner T, Linke S, Müssle B, et al · · 2017 · cited 15× · PMID 28222805 · DOI 10.1186/s13063-017-1782-1
Verify or expand the search:
- PubMed search for NCT02834338
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Technische Universität Dresden trials
Trials by the same sponsor.
- NCT07150598 — Immune-Marker Platform for Patients With Advanced Lung Cancer · not yet recruiting
- NCT06717958 — Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute M · Phase 2 · recruiting
- NCT06701487 — Role of Pavlovian Mechanisms for Control Over Substance Use · recruiting
- NCT03865277 — Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging · Phase 2 · not yet recruiting
- NCT06293170 — Automated Screening for Clinically Ascertained Loss of Cerebral Functions · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02834338 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Technische Universität Dresden
- Last refreshed: 20 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02834338.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing